Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Authors not listed

Novartis · 2003

Abstract

This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with mild cognitive impairment (MCI).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2003). Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment. <em>Novartis</em>. https://clinicaltrials.gov/study/NCT00134953
Vancouver
Anonymous. Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment. Novartis. 2003.
BibTeX
@misc{anon2003Effica, title = {Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment}, author = {Anonymous}, journal = {Novartis}, year = {2003}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings